Development of a Large-Scale Route to Glecaprevir: Synthesis of the Side Chain and Final Assembly

被引:13
作者
Hill, David R. [1 ]
Abrahamson, Michael J. [2 ]
Lukin, Kirill A. [1 ]
Towne, Timothy B. [1 ]
Engstrom, Kenneth M. [1 ]
Reddy, Rajarathnam E. [2 ]
Kielbus, Angelica B. [2 ]
Pelc, Matthew J. [1 ]
Mei, Jianzhang [1 ]
Nere, Nandkishor K. [1 ]
Chen, Shuang [1 ]
Henry, Rodger [1 ]
Chemburkar, Sanjay [2 ]
Ding, Chen [3 ]
Zhang, Hongqiang [3 ]
Cink, Russell D. [1 ]
机构
[1] AbbVie Inc, Proc Res & Dev, N Chicago, IL 60064 USA
[2] AbbVie Inc, Operat Sci & Technol, N Chicago, IL 60064 USA
[3] AbbVie Inc, Analyt Res & Dev, N Chicago, IL 60064 USA
关键词
glecaprevir; ABT-493; HCV; Knoevenagel; chiral resolution; INHIBITORS; ESTERS;
D O I
10.1021/acs.oprd.0c00245
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The preceding article described the development of the large-scale synthetic route to macrocycle 3 of glecaprevir (1), a potent HCV protease inhibitor. This article describes the development of the synthesis of the difluoromethyl-substituted cyclopropyl amino acid 4, its conversion to the fully elaborated side chain, amino sulfonamide 2, and the subsequent final coupling to form glecaprevir. The synthesis of amino acid 4 consists of four key transformations: (a) formation of the difluoromethyl-substituted cyclopropane ring of (+/-)-diester 15 via Knoevenagel condensation and Corey-Chaykovsky cyclopropanation, (b) diastereoselective hydrolysis of (+/-)-diester 15 to yield (+/-)-monoacid 14a-b, (c) conversion of (+/-)-monoacid 14a-b to (+/-)-amino ester 10 via a Curtius rearrangement, and (d) resolution of (+/-)-amino ester 10 followed by saponification to give the desired (1R,2R)-amino acid 4. The large-scale synthetic route to amino acid 4 was successfully used to produce the fully elaborated side chain 2 and ultimately the amount of glecaprevir required to support the late-stage clinical development.
引用
收藏
页码:1393 / 1404
页数:12
相关论文
共 30 条
[21]  
Lukin K. A., 2017, US patent, Patent No. [US9,809,534 BI, 9809534]
[22]  
Mei J., 2019, US Pat.,, Patent No. [010316338B1, 010316338]
[23]   NEW FLUORINATING REAGENTS - DIALKYLAMINOSULFUR FLUORIDES [J].
MIDDLETON, WJ .
JOURNAL OF ORGANIC CHEMISTRY, 1975, 40 (05) :574-578
[24]   Irreversible inhibitors of serine, cysteine, and threonine proteases [J].
Powers, JC ;
Asgian, JL ;
Ekici, ÖD ;
James, KE .
CHEMICAL REVIEWS, 2002, 102 (12) :4639-4750
[25]   A Practical Asymmetric Synthesis of Isopropyl (1R,2S)-Dehydrocoronamate [J].
Tang, Wenjun ;
Wei, Xudong ;
Yee, Nathan K. ;
Patel, Nitinchandra ;
Lee, Heewon ;
Savoie, Jolaine ;
Senanayake, Chris H. .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (05) :1207-1211
[26]   ASYMMETRIC HYDROGENATION - RHODIUM CHIRAL BISPHOSPHINE CATALYST [J].
VINEYARD, BD ;
KNOWLES, WS ;
SABACKY, MJ ;
BACHMAN, GL ;
WEINKAUFF, DJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1977, 99 (18) :5946-5952
[27]   Fluoroalkyl substituted (Z)-dehydro α-amino ester as a building block for the fluorine-containing cyclopropyl α-amino esters and dihydrooxazole [J].
Wan, Wen ;
Gao, Yinghong ;
Jiang, Haizhen ;
Hao, Jian .
JOURNAL OF FLUORINE CHEMISTRY, 2008, 129 (06) :510-514
[28]   Safe Scale-Up of Pharmaceutical Manufacturing Processes with Dimethyl Sulfoxide as the Solvent and a Reactant or a Byproduct [J].
Wang, Zhe ;
Richter, Steven M. ;
Bellettini, John R. ;
Pu, Yu-Ming ;
Hill, David R. .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2014, 18 (12) :1836-1842
[29]   ASYMMETRIC SYNTHESES OF 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID-DERIVATIVES [J].
WILLIAMS, RM ;
FEGLEY, GJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (23) :8796-8806
[30]   Concise synthesis of acyl migration-blocked 1,1-difluorinated analogues of lysophosphatidic acid [J].
Xu, Y ;
Prestwich, GD .
JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (20) :7158-7161